• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Human skin permeation of 3-O-alkyl carbamate prodrugs of naltrexone.纳曲酮 3-O- 烷基氨基甲酸酯前药的人体皮肤渗透。
J Pharm Sci. 2009 Aug;98(8):2611-25. doi: 10.1002/jps.21594.
2
Human skin permeation of branched-chain 3-0-alkyl ester and carbonate prodrugs of naltrexone.纳曲酮的支链3 - O - 烷基酯和碳酸酯前药的人体皮肤渗透情况
Pharm Res. 2005 May;22(5):758-65. doi: 10.1007/s11095-005-2592-9. Epub 2005 May 17.
3
Physicochemical evaluation, in vitro human skin diffusion, and concurrent biotransformation of 3-O-alkyl carbonate prodrugs of naltrexone.纳曲酮3 - O - 烷基碳酸酯前药的物理化学评估、体外人体皮肤扩散及同步生物转化
Pharm Res. 2004 Jul;21(7):1146-52. doi: 10.1023/b:pham.0000033000.03652.73.
4
Straight-chain naltrexone ester prodrugs: diffusion and concurrent esterase biotransformation in human skin.直链纳曲酮酯前药:在人皮肤中的扩散及酯酶的同时生物转化
J Pharm Sci. 2002 Dec;91(12):2571-8. doi: 10.1002/jps.10239.
5
In vitro/in vivo correlation of transdermal naltrexone prodrugs in hairless guinea pigs.无毛豚鼠中透皮纳曲酮前药的体外/体内相关性
Pharm Res. 2005 Jun;22(6):981-9. doi: 10.1007/s11095-005-4593-0. Epub 2005 Jun 8.
6
Enhancement of transdermal delivery of 6-beta-naltrexol via a codrug linked to hydroxybupropion.通过与羟基安非他酮相连的协同药物增强6-β-纳曲醇的透皮递送。
J Control Release. 2006 Jun 28;113(2):137-45. doi: 10.1016/j.jconrel.2006.04.003. Epub 2006 Apr 25.
7
Bioconversion of naltrexone and its 3-O-alkyl-ester prodrugs in a human skin equivalent.纳曲酮及其3 - O - 烷基酯前药在人皮肤等效物中的生物转化。
J Pharm Sci. 2005 Apr;94(4):828-36. doi: 10.1002/jps.20238.
8
In vitro permeation of a pegylated naltrexone prodrug across microneedle-treated skin.经微针处理的皮肤中聚乙二醇化纳曲酮前药的体外渗透。
J Control Release. 2010 Aug 17;146(1):37-44. doi: 10.1016/j.jconrel.2010.05.034. Epub 2010 Jun 4.
9
A duplex "Gemini" prodrug of naltrexone for transdermal delivery.一种用于透皮给药的纳曲酮双功能“双子星”前药。
J Control Release. 2004 Jun 18;97(2):283-90. doi: 10.1016/j.jconrel.2004.03.020.
10
In vivo evaluation of 3-O-alkyl ester transdermal prodrugs of naltrexone in hairless guinea pigs.纳曲酮3 - O - 烷基酯透皮前体药物在无毛豚鼠体内的评价
J Control Release. 2005 Feb 2;102(2):509-20. doi: 10.1016/j.jconrel.2004.10.005.

引用本文的文献

1
Prodrug strategies for enhancing the percutaneous absorption of drugs.提高药物经皮吸收的前药策略。
Molecules. 2014 Dec 12;19(12):20780-807. doi: 10.3390/molecules191220780.
2
Microneedle-assisted percutaneous delivery of naltrexone hydrochloride in yucatan minipig: in vitro-in vivo correlation.微针辅助盐酸纳曲酮经皮给药在尤卡坦小型猪中的研究:体外-体内相关性。
Mol Pharm. 2013 Oct 7;10(10):3745-57. doi: 10.1021/mp400227e. Epub 2013 Sep 23.
3
Optimization of naltrexone diclofenac codrugs for sustained drug delivery across microneedle-treated skin.优化纳曲酮双氯芬酸共前药经微针处理皮肤的持续药物递送。
Pharm Res. 2014 Jan;31(1):148-59. doi: 10.1007/s11095-013-1147-8. Epub 2013 Aug 14.
4
Challenges and opportunities in dermal/transdermal delivery.皮肤/透皮给药的挑战与机遇
Ther Deliv. 2010 Jul;1(1):109-31. doi: 10.4155/tde.10.16.
5
Vehicle composition influence on the microneedle-enhanced transdermal flux of naltrexone hydrochloride.车辆组成对盐酸纳曲酮经皮微针增强通量的影响。
Pharm Res. 2011 Jan;28(1):124-34. doi: 10.1007/s11095-010-0191-x. Epub 2010 Jun 25.

本文引用的文献

1
New lipophilic terbutaline ester prodrugs with long effect duration.具有长效作用的新型亲脂性特布他林酯前药。
Pharm Res. 1984 Jan;1(1):19-23. doi: 10.1023/A:1016322524471.
2
In vivo evaluation of a transdermal codrug of 6-beta-naltrexol linked to hydroxybupropion in hairless guinea pigs.在无毛豚鼠体内对与羟丁丙诺啡相连的6-β-纳曲醇经皮共给药进行评价。
Eur J Pharm Sci. 2008 Apr 23;33(4-5):371-9. doi: 10.1016/j.ejps.2008.01.006. Epub 2008 Jan 31.
3
The role of size and charge for blood-brain barrier permeation of drugs and fatty acids.大小和电荷对药物及脂肪酸血脑屏障渗透的作用。
J Mol Neurosci. 2007 Sep;33(1):32-41. doi: 10.1007/s12031-007-0055-y.
4
The kinetics of inhibition of human acetylcholinesterase and butyrylcholinesterase by two series of novel carbamates.两类新型氨基甲酸酯对人乙酰胆碱酯酶和丁酰胆碱酯酶的抑制动力学
Mol Pharmacol. 2007 Jun;71(6):1610-7. doi: 10.1124/mol.107.033928. Epub 2007 Mar 8.
5
In silico prediction of blood-brain barrier permeation using the calculated molecular cross-sectional area as main parameter.以计算得到的分子横截面积为主要参数进行血脑屏障通透性的计算机模拟预测。
J Chem Inf Model. 2006 Nov-Dec;46(6):2638-50. doi: 10.1021/ci0600814.
6
Structural determinants of Torpedo californica acetylcholinesterase inhibition by the novel and orally active carbamate based anti-alzheimer drug ganstigmine (CHF-2819).新型口服活性氨基甲酸酯类抗阿尔茨海默病药物甘斯的明(CHF-2819)对加州电鳐乙酰胆碱酯酶抑制作用的结构决定因素
J Med Chem. 2006 Aug 24;49(17):5051-8. doi: 10.1021/jm060293s.
7
Synthesis and hydrolytic behavior of two novel tripartate codrugs of naltrexone and 6beta-naltrexol with hydroxybupropion as potential alcohol abuse and smoking cessation agents.纳曲酮和6β-纳曲醇与羟基安非他酮的两种新型三联体协同作用药物的合成及水解行为,作为潜在的酒精滥用和戒烟药物
Bioorg Med Chem. 2006 Oct 15;14(20):7051-61. doi: 10.1016/j.bmc.2006.06.018. Epub 2006 Jun 23.
8
Enhancement of transdermal delivery of 6-beta-naltrexol via a codrug linked to hydroxybupropion.通过与羟基安非他酮相连的协同药物增强6-β-纳曲醇的透皮递送。
J Control Release. 2006 Jun 28;113(2):137-45. doi: 10.1016/j.jconrel.2006.04.003. Epub 2006 Apr 25.
9
Design, synthesis, and biological evaluation of conformationally restricted rivastigmine analogues.构象受限的卡巴拉汀类似物的设计、合成及生物学评价
J Med Chem. 2004 Nov 18;47(24):5945-52. doi: 10.1021/jm049782n.
10
Physicochemical evaluation, in vitro human skin diffusion, and concurrent biotransformation of 3-O-alkyl carbonate prodrugs of naltrexone.纳曲酮3 - O - 烷基碳酸酯前药的物理化学评估、体外人体皮肤扩散及同步生物转化
Pharm Res. 2004 Jul;21(7):1146-52. doi: 10.1023/b:pham.0000033000.03652.73.

纳曲酮 3-O- 烷基氨基甲酸酯前药的人体皮肤渗透。

Human skin permeation of 3-O-alkyl carbamate prodrugs of naltrexone.

机构信息

Department of Pharmaceutical Sciences, University of Kentucky College of Pharmacy, Lexington, Kentucky 40536-0082, USA.

出版信息

J Pharm Sci. 2009 Aug;98(8):2611-25. doi: 10.1002/jps.21594.

DOI:10.1002/jps.21594
PMID:18972573
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2764244/
Abstract

N-Monoalkyl and N,N-dialkyl carbamate prodrugs of naltrexone (NTX), an opioid antagonist, were synthesized and their in vitro permeation across human skin was determined. Relevant physicochemical properties were also determined. Most prodrugs exhibited lower melting points, lower aqueous solubilities, and higher oil solubilities than NTX. The flux values from N-monoalkyl carbamate prodrugs were significantly higher than those from NTX and N,N-dialkyl carbamates. The melting points of N-monoalkyl carbamate prodrugs were quite low compared to the N,N-dialkyl carbamate prodrugs and NTX. Heats of fusion for the N,N-dialkyl carbamate prodrugs were higher than that for NTX. N-Monoalkyl carbamate prodrugs had higher stratum corneum/vehicle partition coefficients than their N,N-dialkyl counterparts. Higher percent prodrug bioconversion to NTX in skin appeared to be related to increased skin flux. N,N-Dialkyl carbamate prodrugs were more stable in buffer and in plasma than N-monoalkyl carbamate prodrugs. In conclusion, N-monoalkyl carbamate prodrugs of NTX improved the systemic delivery of NTX across human skin in vitro. N,N-Dialkyl substitution in the prodrug moiety decreased skin permeation and plasma hydrolysis to the parent drug. The cross-sectional area of the carbamate head group was the major determinant of flux of the N-monoalkyl and N,N-dialkyl carbamate prodrugs of NTX.

摘要

纳曲酮(NTX)的 N-单烷基和 N,N-二烷基氨基甲酸酯前药是一种阿片类拮抗剂,被合成并测定了它们在人体皮肤中的体外渗透情况。还测定了相关的物理化学性质。大多数前药的熔点、水溶解度和油溶解度均低于 NTX。N-单烷基氨基甲酸酯前药的通量值明显高于 NTX 和 N,N-二烷基氨基甲酸酯。与 N,N-二烷基氨基甲酸酯前药和 NTX 相比,N-单烷基氨基甲酸酯前药的熔点相当低。N,N-二烷基氨基甲酸酯前药的熔融热高于 NTX。N-单烷基氨基甲酸酯前药在角质层/载体中的分配系数高于其 N,N-二烷基对应物。皮肤中前药转化为 NTX 的百分比增加似乎与皮肤通量增加有关。N,N-二烷基氨基甲酸酯前药在缓冲液和血浆中的稳定性均高于 N-单烷基氨基甲酸酯前药。总之,NTX 的 N-单烷基氨基甲酸酯前药提高了 NTX 在人体皮肤中的全身递送。前药部分的 N,N-二烷基取代降低了皮肤渗透和母体药物的血浆水解。氨基甲酸酯头部基团的横截面积是 NTX 的 N-单烷基和 N,N-二烷基氨基甲酸酯前药通量的主要决定因素。